Matched-pair analysis of patients with ischemic stroke undergoing thrombectomy using next-generation balloon guide catheters.

Balloon Catheter Stent Stroke Thrombectomy

Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
04 Oct 2023
Historique:
received: 12 07 2023
accepted: 08 09 2023
medline: 5 10 2023
pubmed: 5 10 2023
entrez: 4 10 2023
Statut: aheadofprint

Résumé

Balloon guide catheters (BGCs) have not been widely adopted, possibly due to the incompatibility of past-generation BGCs with large-bore intermediate catheters. The next-generation BGC is compatible with large-bore catheters. We compared outcomes of thrombectomy cases using BGCs versus conventional guide catheters. We conducted a retrospective study of 110 thrombectomy cases using BGCs (n=55) and non-BGCs (n=55). Sixty consecutive thrombectomy cases in whom the BOBBY BGC was used at a single institution between February 2021 and March 2022 were identified. Of these, 55 BGC cases were 1:1 matched with non-BGC cases by proceduralists, age, gender, stent retriever + aspiration device versus aspiration-only, and site of occlusion. First-pass effect was defined as Thrombolysis In Cerebral Infarction 2b or higher with a single pass. The BGC and non-BGC cohorts had similar mean age (67.2 vs 68.9 years), gender distribution (43.6% vs 47.3% women), median initial National Institutes of Health Stroke Scale score (14 vs 15), and median pretreatment ischemic core volumes (12 mL vs 11.5 mL). BGC and non-BGC cases had similar rates of single pass (60.0% vs 54.6%), first-pass effect (58.2% vs 49.1%), and complications (1.8% vs 9.1%). In aspiration-only cases, the BGC cohort had a significantly higher rate of first-pass effect (100% vs 50.0%, p=0.01). BGC was associated with a higher likelihood of achieving a modified Rankin Scale score of 2 at discharge (OR 7.76, p=0.02). No additional procedural time was required for BGC cases (46.7 vs 48.2 min). BGCs may be safely adopted with comparable procedural efficacy, benefits to aspiration-only techniques, and earlier functional improvement compared with conventional guide catheters.

Sections du résumé

BACKGROUND BACKGROUND
Balloon guide catheters (BGCs) have not been widely adopted, possibly due to the incompatibility of past-generation BGCs with large-bore intermediate catheters. The next-generation BGC is compatible with large-bore catheters. We compared outcomes of thrombectomy cases using BGCs versus conventional guide catheters.
METHODS METHODS
We conducted a retrospective study of 110 thrombectomy cases using BGCs (n=55) and non-BGCs (n=55). Sixty consecutive thrombectomy cases in whom the BOBBY BGC was used at a single institution between February 2021 and March 2022 were identified. Of these, 55 BGC cases were 1:1 matched with non-BGC cases by proceduralists, age, gender, stent retriever + aspiration device versus aspiration-only, and site of occlusion. First-pass effect was defined as Thrombolysis In Cerebral Infarction 2b or higher with a single pass.
RESULTS RESULTS
The BGC and non-BGC cohorts had similar mean age (67.2 vs 68.9 years), gender distribution (43.6% vs 47.3% women), median initial National Institutes of Health Stroke Scale score (14 vs 15), and median pretreatment ischemic core volumes (12 mL vs 11.5 mL). BGC and non-BGC cases had similar rates of single pass (60.0% vs 54.6%), first-pass effect (58.2% vs 49.1%), and complications (1.8% vs 9.1%). In aspiration-only cases, the BGC cohort had a significantly higher rate of first-pass effect (100% vs 50.0%, p=0.01). BGC was associated with a higher likelihood of achieving a modified Rankin Scale score of 2 at discharge (OR 7.76, p=0.02). No additional procedural time was required for BGC cases (46.7 vs 48.2 min).
CONCLUSION CONCLUSIONS
BGCs may be safely adopted with comparable procedural efficacy, benefits to aspiration-only techniques, and earlier functional improvement compared with conventional guide catheters.

Identifiants

pubmed: 37793796
pii: jnis-2023-020635
doi: 10.1136/jnis-2023-020635
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Lily H Kim (LH)

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.

John Choi (J)

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.

James Zhou (J)

California Northstate University College of Medicine, Elk Grove, California, USA.

Dylan Wolman (D)

Radiology, Kaiser Permanente, Portland, Oregon, USA.

Arjun V Pendharkar (AV)

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.

Maarten G Lansberg (MG)

Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.

Gregory W Albers (GW)

Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.

Robert Dodd (R)

Neurosurgery and Radiology, Stanford University, Stanford, California, USA.

Huy M Do (HM)

Radiology, Neuroadiology and Neurointervention Division, Stanford University, Stanford, California, USA.

Benjamin Pulli (B)

Radiology, Neuroadiology and Neurointervention Division, Stanford University, Stanford, California, USA.

Jeremy J Heit (JJ)

Radiology, Neuroadiology and Neurointervention Division, Stanford University, Stanford, California, USA.

Nicholas A Telischak (NA)

Radiology, Neuroadiology and Neurointervention Division, Stanford University, Stanford, California, USA ntelischak@gmail.com.

Classifications MeSH